Biology
Longevity & ageing
Ageing biology, mTOR, healthspan, metabolic pathways and the emerging longevity research ecosystem.
Hergemony Life
Life sciences through the lens of research, capital and strategy.
Hergemony Life examines biotechnology, pharmaceuticals, healthcare, longevity and frontier life sciences — connecting scientific developments with company fundamentals, capital allocation, markets and long-term strategic change.
The programme provides a home for life-sciences research and the progressive development of an institutional equity-research capability within Hergemony.
Research domains.
Life is one of Hergemony's core Earth-system domains, studied independently while connecting biological change to economics, policy, technology and capital.
Industry
Biotechnology & pharma
Research pipelines, clinical development, intellectual property, regulation, commercialisation and competitive positioning.
Systems
Healthcare
Healthcare systems, pharmaceuticals, demographics, health economics, access, resilience and strategic health security.
Frontier
Extreme & space life sciences
Human resilience, pharmacology, physiology and biological adaptation in extreme environments and future space systems.
Life Sciences Equity Research.
A disciplined framework for understanding the science, economics and valuation of life-sciences companies.
Hergemony Research Method
01Science
Mechanism, evidence, products, pipeline and clinical or research catalysts.
02Company
Business model, financial statements, management, capital allocation and competitive position.
03Valuation
Forecasts, scenarios, risk, required return, comparable companies and intrinsic value.
04Investment Thesis
Catalysts, risks, conviction, invalidation conditions and subsequent thesis review.
Research pipeline.
The initial programme will build depth deliberately: a small number of serious research projects rather than a large volume of superficial coverage.
Research Theme 001
Longevity, Rapamycin & mTOR
Research into the scientific history, current evidence, companies and investment landscape surrounding rapamycin, mTOR modulation and longevity biotechnology.
ACTIVE RESEARCH THEMECompany Research 001
Longevity Biotechnology
Company-level research examining how modern longevity biotechnology businesses construct pipelines, allocate research capital and translate science into enterprise value.
IN DEVELOPMENTSector Research
Life Sciences Watchlist
A developing universe spanning large-cap pharma, biotechnology, medtech, diagnostics, life-science tools and frontier health technologies.
BUILDINGFrom financial education to institutional research.
Hergemony Life is also a practical research laboratory for developing the core disciplines required in professional life-sciences equity and investment analysis.
| Investment discipline | Life-sciences application | Hergemony capability |
|---|---|---|
| Quantitative Methods | Returns, probabilities, scenario analysis and risk-adjusted outcomes. | Quantitative thesis and scenario framework. |
| Economics | Rates, healthcare demand, policy, funding cycles and macro conditions. | Macro-to-sector transmission analysis. |
| Financial Statements | Revenue, R&D, margins, cash burn, runway, debt and financial quality. | Company fundamentals framework. |
| Corporate Finance | Capital allocation, financing, partnerships, licensing and M&A. | Capital-allocation and resilience analysis. |
| Equity Analysis | Forecasting, valuation, catalysts, risks and investment thesis. | Life Sciences Equity Research. |
| Fixed Income | Cost of capital, refinancing, credit conditions and valuation effects. | Rates and credit transmission. |
| Portfolio Construction | Sector exposure, diversification and portfolio-level healthcare risk. | Portfolio intelligence. |
| Ethics | Research independence, conflicts, information handling and disclosure. | Hergemony Research Standard. |
Institutional Independence
Research first.
Hergemony Life is an analytical programme. Research should distinguish evidence from inference, disclose material assumptions and evaluate scientific and investment claims independently rather than advocate for a predetermined commercial outcome.
Research → Intelligence
Public research, protected intelligence.
Selected research can remain public through Hergemony. Deeper company models, watchlists, valuation work, intelligence tools and capital-allocation systems can progressively sit within Hergemony's authenticated research environment.
Understand the science. Understand the company. Understand the capital.
Hergemony Life